388 A novel library of optimal affinity KRAS mutation-specific T cell receptors associated with multiple HLAs, in combination with a PD1–41BB armoring and enhancement costimulatory switch receptor

• Giulia Longinotti,
• Dolores Schendel,
• Melanie Salvermoser,
• Kathrin Davari,
• Mario Catarinella,
• Julia Bittmann,
• Kirsty Crame

Affiliations

Giulia Longinotti

Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany

Dolores Schendel

3Medigene AG, Planegg-Martinsried, Germany

Melanie Salvermoser

1Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany

Kathrin Davari

Medigene Immunotherapies GmbH, Planegg-Martinsried, Germany

Mario Catarinella

1Medigene AG, Planegg/Martinsried, Bavaria, Germany

Julia Bittmann

1Medigene AG, Planegg/Martinsried, Bavaria, Germany

Kirsty Crame

2Medigene, Munich, Germany